Gilteritinib Fumarate

Gilteritinib Fumarate, sold under the brand name Xospata, is an anti-cancer drug. It acts as an inhibitor of FLT3, hence it is a tyrosine kinase inhibitor.Gilteritinib has been repurposed as a potential antiviral drug as a possible application in the treatment of COVID-19. Reference standards of Gilteritinib Fumarate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Gilteritinib Fumarate - API Standards
    [catalogue_number] => PA 07 1150000
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 1221.52
    [form] => C62H92N16O10
    [cas] => 1254053-84-3
    [pslug] => 1254053-84-3-gilteritinib-fumarate-api-standards-pa071150000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)